64 results on '"L. Moliner"'
Search Results
2. A proof-of-concept of cross-luminescent metascintillators: testing results on a BGO: BaF2metapixel
- Author
-
G Konstantinou, R Latella, L Moliner, L Zhang, J M Benlloch, A J Gonzalez, and P Lecoq
- Subjects
Positron emission tomography ,Radiological and Ultrasound Technology ,Radiology, Nuclear Medicine and imaging ,Instrumentation ,Scintillation ,Front-end detector ,Metascintillators - Abstract
[EN] Objective: Time-of-flight positron emission tomography (PET)is the next frontier in improving the effective sensitivity. To achieve superior timing for time-of-flight PET, combined with high detection efficiency and cost-effectiveness, we have studied the applicability of BaF2 in metascintillators driven by the timing of cross-luminescence photon production. Approach: Based on previous simulation studies of energy sharing and analytic multi-exponential scintillation pulse, as well as sensitivity characteristics, we have experimentally tested a pixel of 3 × 3 × 15 mm3 based on 300 ¿m BGO and 300 ¿m BaF2 layers. To harness the deep ultraviolet cross-luminescent light component, which carries improved timing, we use the FBK VUV SiPM. Metascintillator energy sharing is addressed through a double integration approach. Main results: We reach an energy resolution of 22%, comparable to an 18% resolution of simple BGO pixels using the same readout, through the optimized use of the integrals of the metascintillator pulse in energy sharing calculation. We measure the energy sharing extent of each pulse with a resolution of 25% and demonstrate that experimental and simulation results agree well. Based on the energy sharing, a timewalk correction is applied, exhibiting significant improvements for both the coincidence time resolution (CTR) and the shape of the timing histogram. We reach 242 ps CTR for the entire photopeak, while for a subset of 13% of the most shared events, the CTR value improves to 108 ps, comparable to the 3 × 3 × 5 mm3 LYSO:Ce:Ca reference crystal. Significance: While we are considering different ways to improve further these results, this proof-ofconcept demonstrates the applicability of cross-luminescence for metascintillator designs through the application of VUV compatible SiPM coupling, and easily implementable digital algorithms. This is the first test of BaF2-based metascintillators of sufficient stoppng power to be included in a PET scanner, demonstrating the industrial applicability of such cross-luminescent metascintillators., Part of the research presented in this manuscript was funded by the ERC grant Innovative PET scanner for dynamic imaging, agreement no 695536. The concept presented in this manuscript was based on research first developed within the TICAL: 4D total absorptionTime Imaging CALorimeter ERC grant, agreement no 338953. The authors would like to acknowledge the support of Dr. Daniel Bonifacio of IPEN, Sao Paolo, Brazil.
- Published
- 2023
3. Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
- Author
-
L. Moliner, L. Spurgeon, and R. Califano
- Subjects
Cancer Research ,Oncology - Published
- 2023
- Full Text
- View/download PDF
4. Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage
- Author
-
Xavier Monzonis, Daniel Echeverría-Esnal, Inés Monge-Escartín, Edurne Arriola, L. Moliner, Álvaro Taus, Xavier Duran-Jordà, Alejandro Ríos-Hoyo, and David Conde-Estévez
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,030106 microbiology ,Pembrolizumab ,Gastroenterology ,Body Mass Index ,Hospitals, University ,03 medical and health sciences ,Antineoplastic Agents, Immunological ,Sex Factors ,0302 clinical medicine ,Atezolizumab ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Lung cancer ,Adverse effect ,Immune Checkpoint Inhibitors ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Pharmacology ,business.industry ,Incidence (epidemiology) ,Age Factors ,Immunotherapy ,Middle Aged ,Prognosis ,medicine.disease ,Progression-Free Survival ,Immune checkpoint ,Infectious Diseases ,Socioeconomic Factors ,Oncology ,030220 oncology & carcinogenesis ,Female ,Nivolumab ,business - Abstract
Our aim was to describe the incidence and characteristics of immune-related adverse events (irAEs) in patients with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI) and to evaluate their impact on outcome. All cases of NSCLC patients treated with ICIs in the second-line setting between December 2015 and May 2018 were evaluated. Seventy patients were included. Mean age was 65.9 years, and the majority of male (n = 53, 75.7%), with PS of 0-1 (n = 62, 88.6%) treated with nivolumab (n = 51; 72.9%). Thirty-one patients (44.3%) experienced an AE, 5 (7.1%) were grades 3-4. Median OS in patients with AE was 30.1 months (95% CI, 16.7-43.5) compared with 5.1 months (95% CI, 1.2-9.0) in cases without AE (log-rank test: p = 0.010). The adjusted HR for OS was 0.46 (95% CI, 0.25-0.86) for the irAE occurrence and 3.60 (95% CI, 1.56-8.32) for PS 2-3 group. The development of irAEs was associated with improved patient outcome.
- Published
- 2020
- Full Text
- View/download PDF
5. 205P Pre-existing tumor host immunity characterization in resected non-small cell lung cancer
- Author
-
L.M. Pinto, P. Rocha, M. Rodrigo, L. Moliner, S. Menendez, N. Navarro Gorro, R. Del Rey-Vergara, M.A. Galindo Campos, A. Taus Garcia, I. Sánchez, D. Casadevall Aguilar, S. Clave, B. Bellosillo Paricio, J. Perera, L. Comerma, and E. Arriola
- Subjects
Oncology ,Immunology and Allergy - Published
- 2022
- Full Text
- View/download PDF
6. 66P Real-world data of first-line chemo-immunotherapy for patients with extensive stage SCLC: A multicentre experience from Switzerland and the UK
- Author
-
L. Moliner, N.M. Zellweger, S.M. Schmidt, C. Waibel, P.R. Froesch, P. Häuptle, V. Blum, L. Holer, M. Frueh, S. Bhagani, H-L.J. Gray, S. Cox, T. Khalid, D.C. Scott, S.D. Robinson, L. Hennah, C. Handforth, L.A. Mauti, R. Califano, and S.I. Rothschild
- Subjects
Oncology ,Immunology and Allergy - Published
- 2022
- Full Text
- View/download PDF
7. 1541P Real-world data of atezolizumab plus carboplatin-etoposide for patients with extensive stage SCLC: The UK experience
- Author
-
L. Moliner, L. Woodhouse, S. Ahmed, S. Bhagani, P. Sevak, A. Vijay, N. Steele, H-L.J. Gray, S.D. Robinson, M. Davidson, M.E.R. O'Brien, S. Cox, C. Powell, T. Khalid, null T.R. Geldart, L. Hennah, T. Newsom-Davis, null A. Denton, F. Blackhall, and R. Califano
- Subjects
Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
8. HIGH-SCHOOL MATHEMATICS TEACHERS’ EXPERIENCES REGARDING TEACHING DURING COVID-19 LOCKDOWN IN SPAIN
- Author
-
V. Gil Lorenzo, F. Alegre, and L. Moliner
- Subjects
Coronavirus disease 2019 (COVID-19) ,Mathematics education - Published
- 2021
- Full Text
- View/download PDF
9. 9TH GRADE STUDENTS’ EXPERIENCES REGARDING LEARNING OF MATHEMATICS DURING COVID-19 LOCKDOWN IN SPAIN
- Author
-
V. Gil Lorenzo, L. Moliner, and F. Alegre
- Subjects
Coronavirus disease 2019 (COVID-19) ,Mathematics education - Published
- 2021
- Full Text
- View/download PDF
10. 91P Preexisting tumor host immunity delineates clinical outcomes in resectable non-small cell lung cancer
- Author
-
P. Rocha, M. Rodrigo, L. Moliner, A. Ríos-Hoyo, L. Masfarré, N. Navarro-Gorro, S. Menendez, A. Taus, A. Rodríguez, R. Aguiló, J. Belda, R. Del Rey-Vergara, M. Galindo, L. Comerma, and E. Arriola
- Subjects
Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
11. Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
- Author
-
M. Hardy-Werbin, Álvaro Taus, Didac Ramal, Alex Corbera, Pedro Rocha, Enric Ripoll, Mayra Orrillo, Edurne Arriola, L. Moliner, Joan Gibert, David Casadevall, Júlia Perera-Bel, and Flavio Zuccarino
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Concordance ,medicine.medical_treatment ,NSCLC ,lcsh:RC254-282 ,Immune checkpoint inhibitors ,Hyperprogressive disease ,Internal medicine ,medicine ,Chemotherapy ,business.industry ,Incidence (epidemiology) ,Brief Report ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Docetaxel ,Response Evaluation Criteria in Solid Tumors ,Cohort ,Nivolumab ,business ,Progressive disease ,medicine.drug - Abstract
Introduction Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controversy regarding the concept of HPD. Methods Consecutive patients treated with nivolumab (N = 42) or docetaxel (N = 37) were evaluated. HPD was quantified by applying three different methods (tumor growth rate [TGR], tumor growth kinetics [TGK], and Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1]). HPD rates were compared between and within both cohorts using the different methods. Results Using TGR, TGK, and RECIST 1.1, we identified seven (16.7%), seven (16.7%), and six (14.3%) patients with HPD in the nivolumab cohort and three (8.1%), four (10.8%), and five (13.6%) in the docetaxel cohort, respectively. We observed a higher concordance between TGR and TGK (90.1%) compared with RECIST 1.1 (31.3% and 37.5% with TGR and TGK, respectively). We found no significant differences in the overall survival between patients with progressive disease and HPD in either cohort. Conclusions TGR and TGK revealed high concordance rates for identifying patients with HPD in NSCLC. The incidence of HPD was numerically higher in patients treated with immune checkpoint inhibitors. Standardization of methods for measuring HPD and its exploration in larger studies are needed to establish its clinical meaning in NSCLC.
- Published
- 2020
12. Development of a Standing Equine Leg CT (slCT)
- Author
-
L. Moliner, N. Bolas, E. Pallas, M.J. Rodríguez-Álvarez, and J.M. Benlloch
- Subjects
Instrumentation ,Mathematical Physics - Abstract
All horse ridden disciplines result in stresses to both bony and soft tissue structures. Many competitive horses experience extreme forces on the structures of the lower limb whilst executing transitions such as a tight turns or rapid acceleration. Lameness subsequent to distal limb injury is common to both the performance and pleasure horse, resulting in time out of ridden work at best or career ending at worst. In this context, Hallmarq Veterinary Imaging Ltd (a company dedicated to veterinary imaging) and the Institute of Instrumentation for Molecular Imaging (i3M) established a collaboration in order to develop a CT prototype device for the examination of horse limbs. The Standing Equine Leg CT (slCT) is an additional tool for equine veterinarians to fully evaluate and diagnose lameness, fracture and disease in the equine distal limb.
- Published
- 2022
- Full Text
- View/download PDF
13. 53P Antitumoral effects of the Met inhibitor savolitinib in combination with durvalumab in a syngeneic small cell lung cancer mouse model
- Author
-
Carlos Martinez, Edurne Arriola, Ana Rovira, Miguel Galindo-Campos, Álvaro Taus, L. Moliner, S. González-Gallardo, M. Hardy-Werbin, R. Del Rev-Vergara, A. Ríos-Hoyo, and M. Carpes
- Subjects
Pulmonary and Respiratory Medicine ,Durvalumab ,Oncology ,Savolitinib ,business.industry ,Cancer research ,Medicine ,Non small cell ,business - Published
- 2021
- Full Text
- View/download PDF
14. 1660P Changes in the pattern of diagnosis and treatment of patients with SCLC in the last 20 years
- Author
-
S. González Gallardo, Álvaro Taus, R. del Rey Vergara, Edurne Arriola, L. Moliner, A. Rios Hoyo, X. Durán, N. Navarro, M. Hardy-Werbin, and M.A. Galindo Campos
- Subjects
Pediatrics ,medicine.medical_specialty ,Oncology ,business.industry ,Medicine ,Hematology ,business - Published
- 2021
- Full Text
- View/download PDF
15. 975P Impact of body mass index on the efficacy of immune checkpoint inhibitors in cancer
- Author
-
Álvaro Taus, X. Monzonís, L. Moliner, D. Conde, Edurne Arriola, N. Navarro, M. Hardy-Werbin, X. Durán, I. Monge Escartin, and A. Rios Hoyo
- Subjects
Oncology ,business.industry ,Immune checkpoint inhibitors ,Cancer research ,Medicine ,Cancer ,Hematology ,business ,medicine.disease ,Body mass index - Published
- 2021
- Full Text
- View/download PDF
16. ROS1 non-small cell lung cancer patients treatment approach
- Author
-
L. Moliner and Edurne Arriola
- Subjects
Cancer Research ,Oncology (nursing) ,business.industry ,medicine.disease ,Anesthesiology and Pain Medicine ,Oncology ,Cancer research ,ROS1 ,Medicine ,Pharmacology (medical) ,Surgery ,Non small cell ,business ,Lung cancer - Published
- 2021
- Full Text
- View/download PDF
17. MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside
- Author
-
Edurne Arriola, Raúl Del Rey-Vergara, L. Moliner, M. Hardy-Werbin, and Miguel Galindo-Campos
- Subjects
0301 basic medicine ,Cancer Research ,medicine.medical_treatment ,Review ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Medicine ,Tumor growth ,HGF ,Lung cancer ,business.industry ,Immunotherapy ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Preclinical data ,respiratory tract diseases ,Clinical trial ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,MET ,Hepatocyte growth factor ,Non small cell ,small cell lung cancer ,immunotherapy ,business ,medicine.drug - Abstract
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer. The different systemic treatment approaches attempted in the last 35 years have not improved overall survival in the advanced stage. Targeted therapies assessed in clinical trials have failed to show efficacy against SCLC. Within the potentially interesting targets, the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition (MET) pathway activation is associated with worse survival and chemoresistance in SCLC. Preclinical data suggest that the inhibition of the MET pathway can revert chemoresistance and prevent tumor growth. Recently, immunotherapy has shown modest but relevant activity in SCLC. Interestingly, MET modulation seems to be involved in increasing the efficacy of standard checkpoint inhibitors. Here, we review the preclinical and clinical data of MET inhibition in SCLC, and the role of this pathway in the immune response.
- Published
- 2019
18. 111P Adenosine pathway and exhaustion markers in peripheral T-cell correlate with benefit from immunotherapy in advanced non-small cell lung cancer
- Author
-
X. Villanueva, Sandra M. Gonzalez, Pedro Rocha, Oriol Arpí, R. Del Rey-Vergara, Edurne Arriola, M. Hardy-Werbin, Miguel Galindo-Campos, Álvaro Taus, and L. Moliner
- Subjects
business.industry ,medicine.medical_treatment ,T cell ,Hematology ,Immunotherapy ,medicine.disease ,Adenosine ,Peripheral ,medicine.anatomical_structure ,Oncology ,medicine ,Cancer research ,Non small cell ,Lung cancer ,business ,medicine.drug - Published
- 2020
- Full Text
- View/download PDF
19. Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab
- Author
-
Jaume Capellades, Edurne Arriola, L. Moliner, and Álvaro Taus
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Oncology ,business.industry ,medicine ,Case Report ,Pembrolizumab ,Radiology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,business ,lcsh:RC254-282 ,Pseudoprogression - Published
- 2020
- Full Text
- View/download PDF
20. Accurate Identification of Predictive Biomarkers of Response to Targeted Therapies in Lung Cancer With Next Generation Sequencing
- Author
-
L. Moliner, Concepción Fernández, Sergi Clavé, and Edurne Arriola
- Subjects
Pulmonary and Respiratory Medicine ,business.industry ,medicine ,Identification (biology) ,General Medicine ,Computational biology ,Lung cancer ,medicine.disease ,business ,DNA sequencing ,Predictive biomarker - Published
- 2019
- Full Text
- View/download PDF
21. Association between serum HGF levels and neutrophil counts in small cell lung cancer and their impact on survival
- Author
-
Ana Rovira, R. Del Rey, L. Moliner, Oriol Arpí, Joan Albanell, Álvaro Taus, X. Durán, Miguel Galindo-Campos, M. Hardy-Werbin, Edurne Arriola, and Pedro Rocha
- Subjects
Oncology ,medicine.medical_specialty ,Multivariate analysis ,medicine.diagnostic_test ,business.industry ,Proportional hazards model ,Hematology ,Disease ,Chemotherapy regimen ,Internal medicine ,medicine ,Absolute neutrophil count ,Blood test ,Non small cell ,Extensive stage ,business ,health care economics and organizations - Abstract
Background Small cell lung cancer (SCLC) is a highly lethal disease. Recently, immunotherapy has demonstrated a benefit for a subgroup of patients beyond the second-line and in the first-line setting combined with chemotherapy. However, the majority of patients will not benefit and predictive biomarkers are urgently needed. High baseline neutrophil count (NC) and neutrophil-to-lymphocyte ratio (NLR) are unfavorable prognostic factors in SCLC and might also predict for lack of response to immunotherapy. There is data suggesting that activation of the HGF/MET pathway might contribute to the recruitment of immunosuppressor neutrophils in the tumor. Our aim was to evaluate the association between HGF serum levels (sHGF) and NC in SCLC and their impact on outcome. Methods Serum samples from SCLC patients were obtained before starting first-line treatment. We used the Quantikine Human HGF Immunoassay to quantify sHGF. All samples were run in duplicates. NC and NLR were obtained from blood test reports before treatment initiation. Statistical analysis was carried out using SPSS 22.0 and Prism 8.1.0. Correlation of variables was assessed by the Spearman’s correlation coefficient. Multivariate analysis was performed with the Cox regression method. Results Samples from 105 patients diagnosed with SCLC at our institution were included. 79.1% of the cases were male, 73.3% with extensive stage, and 31.4% had an ECOG score of ≥ 2. Median sHGF, NC and NLR were 1875.38pg/ml, 6440/µl and 5.1 respectively. Patients with baseline NLR > 4 or NC above median had worse median overall survival (mOS), with 7.9 vs 15.3 months (m) (p Conclusions Baseline HGF levels correlate with NC in SCLC, reinforcing the hypothesis of a plausible interplay between HGF/MET axis and the immune system. The role of these parameters as predictive biomarkers of response to immunotherapy in SCLC warrants further investigation. Legal entity responsible for the study The authors. Funding Has not received any funding. Disclosure E. Arriola: Speaker Bureau / Expert testimony: BMS; Speaker Bureau / Expert testimony: Roche; Speaker Bureau / Expert testimony: MSD; Speaker Bureau / Expert testimony: Pfizer; Speaker Bureau / Expert testimony: Lilly; Speaker Bureau / Expert testimony: AstraZeneca; Research grant / Funding (institution): BMS; Research grant / Funding (institution): Roche; Research grant / Funding (institution): Pfizer; Research grant / Funding (institution): PGDx; Travel / Accommodation / Expenses: BMS; Travel / Accommodation / Expenses: MSD; Travel / Accommodation / Expenses: Roche; Travel / Accommodation / Expenses: Lilly. All authors have declared no conflicts of interest.
- Published
- 2019
- Full Text
- View/download PDF
22. Higher PD-L1 expression correlates with lymphocyte infiltration in early non-small cell lung cancer
- Author
-
L. Moliner, X. Durán, M. Salido, X. Riera, Pedro Rocha, M. Rodrigo, Silvia Menendez, Lara Pijuan, M. Hardy-Werbin, L. Comerma, D. Casadevall Aguilar, Álvaro Taus, Sergi Clavé, Oriol Arpí, and E. Arriola Aperribay
- Subjects
Lymphocyte infiltration ,Oncology ,business.industry ,medicine ,Cancer research ,Pd l1 expression ,Hematology ,Non small cell ,Lung cancer ,medicine.disease ,business - Published
- 2019
- Full Text
- View/download PDF
23. A novel semi-robotized device for high-precision
- Author
-
D, Hellingman, S C, Teixeira, M L, Donswijk, E J, Rijkhorst, L, Moliner, J, Alamo, C E, Loo, R A, Valdés Olmos, and M P M, Stokkel
- Subjects
Image-Guided Biopsy ,Robotic Surgical Procedures ,Fluorodeoxyglucose F18 ,Biopsy, Needle ,Humans ,Breast Neoplasms ,Female ,Breast ,Equipment Design ,Radiopharmaceuticals - Abstract
To assess the 3D geometric sampling accuracy of a new PET-guided system for breast cancer biopsy (BCB) from areas within the tumour with highIn the context of the European Union project MammoCare, a prototype semi-robotic stereotactic prototype BCB-device was incorporated into a dedicated high resolution PET-detector for breast imaging. The system consists of 2 stacked rings, each containing 12 plane detectors, forming a dodecagon with a 186mm aperture for 3D reconstruction (1mmNeedle positioning tests revealed an average accuracy of 0.5mm (range 0-1mm), 0.6mm (range 0-2mm), and 0.4mm (range 0-2mm) for the x/y/z-axes, respectively. Furthermore, the MammoCare system was able to visualize and locate small (10mm) regions with highAccuracy testing demonstrated high-precision of this semi-automatic 3D PET-guided system for breast cancer core needle biopsy. Its clinical feasibility evaluation in breast cancer patients scheduled for neo-adjuvant chemotherapy will follow.
- Published
- 2016
24. Ataxioceras (Ataxioceras) lopeztichae Cantú-Chapa, 1991: Updating the systematic and palaeobiogeographic interpretation
- Author
-
F Olóriz, L Moliner, and A Villaseñor
- Subjects
0301 basic medicine ,03 medical and health sciences ,030104 developmental biology ,business.industry ,Interpretation (philosophy) ,Artificial intelligence ,Oceanography ,computer.software_genre ,business ,computer ,Geology ,Natural language processing - Published
- 2016
- Full Text
- View/download PDF
25. ALBIRA: a small animal PET∕SPECT∕CT imaging system
- Author
-
F, Sánchez, A, Orero, A, Soriano, C, Correcher, P, Conde, A, González, L, Hernández, L, Moliner, M J, Rodríguez-Alvarez, L F, Vidal, J M, Benlloch, S E, Chapman, and W M, Leevy
- Subjects
Tomography, Emission-Computed, Single-Photon ,Mice ,Positron-Emission Tomography ,Calibration ,Image Processing, Computer-Assisted ,Animals ,Equipment Design ,Tomography, X-Ray Computed ,Multimodal Imaging ,Rats - Abstract
The authors have developed a trimodal PET∕SPECT∕CT scanner for small animal imaging. The gamma ray subsystems are based on monolithic crystals coupled to multianode photomultiplier tubes (MA-PMTs), while computed tomography (CT) comprises a commercially available microfocus x-ray tube and a CsI scintillator 2D pixelated flat panel x-ray detector. In this study the authors will report on the design and performance evaluation of the multimodal system.X-ray transmission measurements are performed based on cone-beam geometry. Individual projections were acquired by rotating the x-ray tube and the 2D flat panel detector, thus making possible a transaxial field of view (FOV) of roughly 80 mm in diameter and an axial FOV of 65 mm for the CT system. The single photon emission computed tomography (SPECT) component has a dual head detector geometry mounted on a rotating gantry. The distance between the SPECT module detectors can be varied in order to optimize specific user requirements, including variable FOV. The positron emission tomography (PET) system is made up of eight compact modules forming an octagon with an axial FOV of 40 mm and a transaxial FOV of 80 mm in diameter. The main CT image quality parameters (spatial resolution and uniformity) have been determined. In the case of the SPECT, the tomographic spatial resolution and system sensitivity have been evaluated with a (99m)Tc solution using single-pinhole and multi-pinhole collimators. PET and SPECT images were reconstructed using three-dimensional (3D) maximum likelihood and ordered subset expectation maximization (MLEM and OSEM) algorithms developed by the authors, whereas the CT images were obtained using a 3D based FBP algorithm.CT spatial resolution was 85 μm while a uniformity of 2.7% was obtained for a water filled phantom at 45 kV. The SPECT spatial resolution was better than 0.8 mm measured with a Derenzo-like phantom for a FOV of 20 mm using a 1-mm pinhole aperture collimator. The full width at half-maximum PET radial spatial resolution at the center of the field of view was 1.55 mm. The SPECT system sensitivity for a FOV of 20 mm and 15% energy window was 700 cps∕MBq (7.8 × 10(-2)%) using a multi-pinhole equipped with five apertures 1 mm in diameter, whereas the PET absolute sensitivity was 2% for a 350-650 keV energy window and a 5 ns timing window. Several animal images are also presented.The new small animal PET∕SPECT∕CT proposed here exhibits high performance, producing high-quality images suitable for studies with small animals. Monolithic design for PET and SPECT scintillator crystals reduces cost and complexity without significant performance degradation.
- Published
- 2013
26. Laser Acceleration of Protons and Ions at Salamanca
- Author
-
M Seimetz, P Bellido, J I Apiñaniz, P Conde, E Crespo, M Galán, A J González, L Hernández, A Iborra, R Lera, F Martos, L Moliner, A Peralta Conde, M Rico, J P Rigla, M J Rodríguez-Álvarez, L Roso, F Sánchez, M Sánchez Albaneda, A Soriano, F Valle Brozas, L F Vidal, and J M Benlloch
- Published
- 2013
- Full Text
- View/download PDF
27. Small animal PET scanner based on monolithic LYSO crystals: performance evaluation
- Author
-
F, Sanchez, L, Moliner, C, Correcher, A, Gonzalez, A, Orero, M, Carles, A, Soriano, M J, Rodriguez-Alvarez, L A, Medina, F, Mora, and J M, Benlloch
- Subjects
Equipment Failure Analysis ,Mice ,Phantoms, Imaging ,Positron-Emission Tomography ,Animals ,Reproducibility of Results ,Heart ,Equipment Design ,Image Enhancement ,Sensitivity and Specificity - Abstract
The authors have developed a small animal Positron emission tomography (PET) scanner based on monolithic LYSO crystals coupled to multi-anode photomultiplier tubes (MA-PMTs). In this study, the authors report on the design, calibration procedure, and performance evaluation of a PET system that the authors have developed using this innovative nonpixelated detector design.The scanner is made up of eight compact modules forming an octagon with an axial field of view (FOV) of 40 mm and a transaxial FOV of 80 mm diameter. In order to fully determine its performance, a recently issued National Electrical Manufacturers Association (NEMA) NU-4 protocol, specifically developed for small animal PET scanners, has been followed. By measuring the width of light distribution collected in the MA-PMT the authors are able to determine depth of interaction (DOI), thus making the proper identification of lines of response (LORs) with large incidence angles possible. PET performances are compared with those obtained with currently commercially available small animal PET scanners.At axial center when the point-like source is located at 5 mm from the radial center, the spatial resolution measured was 1.65, 1.80, and 1.86 mm full width at half maximum (FWHM) for radial, tangential, and axial image profiles, respectively. A system scatter fraction of 7.5% (mouse-like phantom) and 13% (rat-like phantom) was obtained, while the maximum noise equivalent count rate (NECR) was 16.9 kcps at 12.7 MBq (0.37 MBq/ml) for mouse-like phantom and 12.8 kcps at 12.4 MBq (0.042 MBq/ml) for rat-like phantom The peak absolute sensitivity in the center of the FOV is 2% for a 30% peak energy window. Several animal images are also presented.The overall performance of our small animal PET is comparable to that obtained with much more complex crystal pixelated PET systems. Moreover, the new proposed PET produces high-quality images suitable for studies with small animals.
- Published
- 2012
28. Nephrolithiasis and pyelonephritis in two West Indian manatees (Trichechus manatus spp.)
- Author
-
Orestes Bello, José L. Moliner, Scott Gearhart, Alex M. Costidis, Maron B. Calderwood Mays, Martha Keller, Sentiel A. Rommel, Grettys Vásquez, and Danilo Cruz
- Subjects
medicine.medical_specialty ,Pathology ,Conservation of Natural Resources ,Ecology ,biology ,Pyelonephritis ,Interstitial nephritis ,Trichechus manatus ,Physiology ,Animals, Wild ,medicine.disease ,Nephrolithiasis ,biology.animal ,Manatee ,West Indian Manatees ,medicine ,Animals ,Histopathology ,Kidney stones ,Female ,Nephrocalcinosis ,Ecology, Evolution, Behavior and Systematics ,Calculus (medicine) ,Blood Chemical Analysis - Abstract
Two West Indian manatees (Trichechus manatus spp.) were reported with severe emaciation. One animal was a Florida manatee from the Everglades; the other was an Antillean manatee from Cuba. On necropsy, both animals had nephrolithiasis, pyelonephritis, and moderate to severe renomegaly. Histopathology revealed multifocal to diffuse pyelonephritis, interstitial nephritis, and nephrocalcinosis. The stones were analyzed and consisted primarily of calcium carbonate. Serum chemistry values for the Florida animal revealed no renal abnormalities. The mechanism of calculus formation remains unclear in manatees. In horses, another hindgut fermenter, the most common urolith is also calcium carbonate. Urinalyses performed on manatees are very similar to those of horses (i.e., alkaline urine, low specific gravity, and calcium carbonate crystals). Formation of uroliths in manatees may have a pathogenesis similar to equine urolithiasis.
- Published
- 2008
29. SHR3 function is linked to COPII mediated ER vesicle formation
- Author
-
C. F. Gilstring, Per O. Ljungdahl, A. L. Moliner, and Monika Melin-Larsson
- Subjects
Saccharomyces cerevisiae Proteins ,Amino Acid Transport Systems ,Protein Conformation ,Vesicular Transport Proteins ,Saccharomyces cerevisiae ,Endoplasmic Reticulum ,Microbiology ,Fungal Proteins ,Gene Expression Regulation, Fungal ,SNAP23 ,Cloning, Molecular ,COPII ,Sequence Deletion ,Recombination, Genetic ,Chemistry ,Endoplasmic reticulum ,Vesicle ,Cell Membrane ,Membrane Proteins ,Membrane Transport Proteins ,SNAP25 ,General Medicine ,Transport protein ,Cell biology ,DNA-Binding Proteins ,Nuclear Pore Complex Proteins ,Secretory protein ,Unfolded protein response - Published
- 1996
- Full Text
- View/download PDF
30. SYNTHESIS OF TRIGLYCERIDES FROM CINNAMIC ACID AND GLYCEROL USING SUPPORTED SULPHONIC ACIDS
- Author
-
M. Ladero, L. Molinero, F. Sanchez, and F. Garcia-Ochoa
- Subjects
Chemical engineering ,TP155-156 ,Computer engineering. Computer hardware ,TK7885-7895 - Abstract
Not available.
- Published
- 2009
- Full Text
- View/download PDF
31. Strategies of statistical windows in PET image reconstruction to improve the user’s real time experience.
- Author
-
L Moliner, C Correcher, V Gimenez-Alventosa, V Ilisie, J Alvarez, S Sanchez, and M J Rodríguez-Alvarez
- Published
- 2017
- Full Text
- View/download PDF
32. Improving PET sensitivity with a Compton algorithm.
- Author
-
V. Ilisie, V. Giménez-Alventosa, L. Moliner, A. Aguilar, E. Lamprou, A. González, F. Sánchez, and J.M. Benlloch
- Published
- 2017
- Full Text
- View/download PDF
33. Warming reduces trophic diversity in high-latitude food webs.
- Author
-
Jackson MC, O'Gorman EJ, Gallo B, Harpenslager SF, Randall K, Harris DN, Prentice H, Trimmer M, Sanders I, Dumbrell AJ, Cameron TC, Layer-Dobra K, Bespalaya Y, Aksenova O, Friberg N, Moliner Cachazo L, Brooks SJ, and Woodward G
- Subjects
- Animals, Iceland, Russia, Rivers, Biomass, Temperature, Carbon Isotopes analysis, Food Chain, Global Warming, Biodiversity
- Abstract
The physical effects of climate warming have been well documented, but the biological responses are far less well known, especially at the ecosystem level and at large (intercontinental) scales. Global warming over the next century is generally predicted to reduce food web complexity, but this is rarely tested empirically due to the dearth of studies isolating the effects of temperature on complex natural food webs. To overcome this obstacle, we used 'natural experiments' across 14 streams in Iceland and Russia, with natural warming of up to 20°C above the coldest stream in each high-latitude region, where anthropogenic warming is predicted to be especially rapid. Using biomass-weighted stable isotope data, we found that community isotopic divergence (a universal, taxon-free measure of trophic diversity) was consistently lower in warmer streams. We also found a clear shift towards greater assimilation of autochthonous carbon, which was driven by increasing dominance of herbivores but without a concomitant increase in algal stocks. Overall, our results support the prediction that higher temperatures will simplify high-latitude freshwater ecosystems and provide the first mechanistic glimpses of how warming alters energy transfer through food webs at intercontinental scales., (© 2024 The Author(s). Global Change Biology published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
34. Design and proof of concept of a double-panel TOF-PET system.
- Author
-
Gonzalez-Montoro A, Pavón N, Barberá J, Cuarella N, González AJ, Jiménez-Serrano S, Lucero A, Moliner L, Sánchez D, Vidal K, and Benlloch JM
- Abstract
Objective: Positron Emission Tomography (PET) is a well-known imaging technology for the diagnosis, treatment, and monitoring of several diseases. Most PET scanners use a Ring-Shaped Detector Configuration (RSDC), which helps obtain homogeneous image quality but are restricted to an invariable Field-of-View (FOV), scarce spatial resolution, and low sensitivity. Alternatively, few PET systems use Open Detector Configurations (ODC) to permit an accessible FOV adaptable to different target sizes, thus optimizing sensitivity. Yet, to compensate the lack of angular coverage in ODC-PET, developing a detector with high-timing performance is mandatory to enable Time-of-Flight (TOF) techniques during reconstruction. The main goal of this work is to provide a proof of concept PET scanner appropriate for constructing the new generation of ODC-PET suitable for biopsy guidance and clinical intervention during acquisition. The designed detector has to be compact and robust, and its requirements in terms of performance are spatial and time resolutions < 2 mm and < 200 ps, respectively., Methods: The present work includes a simulation study of an ODC-PET based on 2-panels with variable distance. The image quality (IQ) and Derenzo phantoms have been simulated and evaluated. The phantom simulations have also been performed using a ring-shaped PET for comparison purposes of the ODC approach with conventional systems. Then, an experimental evaluation of a prototype detector that has been designed following the simulation results is presented. This study focused on tuning the ASIC parameters and evaluating the scintillator surface treatment (ESR and TiO
2 ), and configuration that yields the best Coincidence Time Resolution (CTR). Moreover, the scalability of the prototype to a module of 64 × 64mm2 and its preliminary evaluation regarding pixel identification are provided., Results: The simulation results reported sensitivity (%) values at the center of the FOV of 1.96, 1.63, and 1.18 for panel distances of 200, 250, and 300 mm, respectively. The IQ reconstructed image reported good uniformity (87%) and optimal CRC values, and the Derenzo phantom reconstruction suggests a system resolution of 1.6-2 mm. The experimental results demonstrate that using TiO2 coating yielded better detector performance than ESR. Acquired data was filtered by applying an energy window of ± 30% at the photopeak level. After filtering, best CTR of 230 ± 2 ps was achieved for an 8 × 8 LYSO pixel block with 2 × 2 × 12mm3 each. The detector performance remained constant after scaling-up the prototype to a module of 64 × 64mm2 , and the flood map demonstrates the module's capabilities to distinguish the small pixels; thus, a spatial resolution < 2 mm (pixel size) is achieved., Conclusions: The simulated results of this biplanar scanner show high performance in terms of image quality and sensitivity. These results are comparable to state-of-the-art PET technology and, demonstrate that including TOF information minimizes the image artifacts due to the lack of angular projections. The experimental results concluded that using TiO2 coating provide the best performance. The results suggest that this scanner may be suitable for organ study, breast, prostate, or cardiac applications, with good uniformity and CRC., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
35. Regional impacts of warming on biodiversity and biomass in high latitude stream ecosystems across the Northern Hemisphere.
- Author
-
Jackson MC, Friberg N, Moliner Cachazo L, Clark DR, Mutinova PT, O'Gorman EJ, Kordas RL, Gallo B, Pichler DE, Bespalaya Y, Aksenova OV, Milner A, Brooks SJ, Dunn N, Lee KWK, Ólafsson JS, Gíslason GM, Millan L, Bell T, Dumbrell AJ, and Woodward G
- Subjects
- Animals, Biomass, Biodiversity, Invertebrates, Ecosystem, Rivers
- Abstract
Warming can have profound impacts on ecological communities. However, explorations of how differences in biogeography and productivity might reshape the effect of warming have been limited to theoretical or proxy-based approaches: for instance, studies of latitudinal temperature gradients are often conflated with other drivers (e.g., species richness). Here, we overcome these limitations by using local geothermal temperature gradients across multiple high-latitude stream ecosystems. Each suite of streams (6-11 warmed by 1-15°C above ambient) is set within one of five regions (37 streams total); because the heating comes from the bedrock and is not confounded by changes in chemistry, we can isolate the effect of temperature. We found a negative overall relationship between diatom and invertebrate species richness and temperature, but the strength of the relationship varied regionally, declining more strongly in regions with low terrestrial productivity. Total invertebrate biomass increased with temperature in all regions. The latter pattern combined with the former suggests that the increased biomass of tolerant species might compensate for the loss of sensitive species. Our results show that the impact of warming can be dependent on regional conditions, demonstrating that local variation should be included in future climate projections rather than simply assuming universal relationships., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
36. Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.
- Author
-
Rocha P, Rodrigo M, Moliner L, Menendez S, Masfarré L, Navarro N, Del Rey-Vergara R, Galindo-Campos M, Taus Á, Giner M, Sanchez I, Rodríguez-Fuster A, Aguiló R, Chalela R, Sánchez-Font A, Belda J, Curull V, Pijuan L, Casadevall D, Clavé S, Bellosillo B, Perera-Bel J, Comerma L, and Arriola E
- Subjects
- Humans, B7-H1 Antigen metabolism, Biomarkers, Forkhead Transcription Factors metabolism, Biomarkers, Tumor metabolism, Tumor Microenvironment, Lymphocytes, Tumor-Infiltrating, Carcinoma, Non-Small-Cell Lung pathology, Lung Neoplasms pathology, Adenocarcinoma of Lung metabolism
- Abstract
Introduction: Neoadjuvant and adjuvant immune checkpoint blockade (ICB) have recently become standard of care in resectable non-small cell lung cancer (NSCLC). Yet, biomarkers that inform patients who benefit from this approach remain largely unknown. Here, we interrogated the tumor immune microenvironment (TIME) in early-stage NSCLC patients that underwent up-front surgery., Methods: A total of 185 treatment-naïve patients with early-stage NSCLC, that underwent up-front surgical treatment between 2006 and 2018 at Hospital del Mar were included. 124 lung adenocarcinomas (LUADs), and 61 squamous cell carcinoma (LUSCs) were included in a tissue microarray. Immunohistochemistry for CD3, CD4, CD8, CD68, CD80, CD103, FOXP3, PD-1, PD-L1, PD-L2 and HLA class II were evaluated by digital image analysis (QuPath software). TIME was categorized into four groups using PD-L1 expression in tumor cells (<1 % or ≥1 %) and tumor resident memory (CD103
+ ) immune cells (using the median as cut-off). We explored the association between different TIME dimensions and patient's clinicopathological features and outcomes., Results: We found increased levels of T cell markers (CD3+ , CD4+ , CD8+ cells), functional immune markers (FOXP3+ cells) as well as, higher HLA-II tumor membrane expression in LUADs compared to LUSCs (p < 0.05 for all). In contrast, LUSCs displayed higher percentage of intratumor macrophages (CD68+ cells) as well as, higher PD-L1 and PD-L2 tumor membrane expression (p < 0.05 for all). Unsupervised analysis revealed three different tumor subsets characterized by membrane tumor expression of PD-L1, PD-L2 and HLA-class II. Enrichment of T cells (CD3+ , CD8+ cells), regulatory T cells (FOXP3+ cells) and macrophages (CD68+ cells) was observed in the CD103+ /PD-L1+ group (p < 0.05 for all). Multivariate analysis showed that infiltration by CD103+ immune cells was associated with improved OS (p = 0.009)., Conclusions: TIME analysis in resected NSCLC highlighted differences by histology, PD-L1 expression and molecular subgroups. Biomarker studies using IHC might aid to individually tailor adjuvant treatment in early-stage NSCLC., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:P. Rocha reports travel support from AstraZeneca. A. Taus reports personal fees and non-financial support from Takeda, Sanofi, Roche, BMS, MSD, GSK, Astrazeneca and Pfizer, outside the submitted work. R. Chalela reports travel and personal fees from Chiesi, GSK and AstraZeneca, outside the submitted work. B. Bellosillo reports grants, personal fees and non-financial support from Roche, grants, personal fees and non-financial support from ThermoFisher, grants, personal fees and non-financial support from Astra-Zeneca, personal fees and non-financial support from Merck-Serono, personal fees and non-financial support from Novartis, personal fees and non-financial support from Qiagen, personal fees and non-financial support from Pfizer, personal fees and non-financial support from BMS. L. Comerma reports personal fees and non-financial support from Roche, personal fees and non-financial support from MSD and personal fees from Diaceutics, outside the submitted work. E. Arriola reports grants, personal fees and non-financial support from Roche, personal fees, and non-financial support from BMS, personal fees and non-financial support from MSD, personal fees from Astra Zeneca, grants and personal fees from Pfizer, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Lilly, personal fees from Takeda, outside the submitted work. Remain authors have no competing interests to declare., (Copyright © 2023 Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
37. Novel therapeutic strategies for recurrent SCLC.
- Author
-
Moliner L, Zhang B, Lamberti G, Ardizzoni A, Byers LA, and Califano R
- Subjects
- Humans, Neoplasm Recurrence, Local drug therapy, Immunotherapy, Prognosis, Lung Neoplasms therapy, Lung Neoplasms drug therapy, Small Cell Lung Carcinoma drug therapy
- Abstract
Therapeutic options for patients with relapsed SCLC are limited, and the prognosis in this setting remains poor. While clinical outcomes for frontline treatment have modestly improved with the introduction of immunotherapy, treatment in the second-line setting persists almost unchanged. In this review, current treatment options and recent advances in molecular biology are described. Emerging therapeutic options in this setting, and potential strategies to improve clinical outcomes of these patients are also addressed., Competing Interests: Declaration of Competing Interest AA reports research grants from Celgene, BMS, Ipsen, Roche; honoraria for advisory board participation from BMS, MSD, ROCHE, AstraZeneca, Eli-Lilly. LB received research funding from AstraZeneca, Amgen, Jazz Pharmaceuticals; served as an advisor/consultant for Merck Sharp & Dohme Corp., Arrowhead Pharmaceuticals, Chugai Pharma, AstraZeneca, Abbvie, BeiGene, Jazz Pharmaceuticals, Genentech. RC reports honoraria, consulting or advisory role from AstraZeneca, BMS, Roche, MSD, Boehringer Ingelheim, Takeda, Bayer, Sanofi, Pharmamar, Lilly Oncology, Janssen, Amgen and Novartis. LM, BZ and GL declare no conflicts of interest., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
38. Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
- Author
-
Moliner L, Spurgeon L, and Califano R
- Subjects
- Humans, Immunotherapy, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms drug therapy
- Abstract
Competing Interests: Disclosure RC: honoraria and consulting or advisory role: AstraZeneca, Bristol Myers Squibb, Roche, Merck Sharp & Dohme, Boehringer Ingelheim, Takeda, Bayer, Sanofi, Pharmamar, Lilly Oncology, Janssen, Amgen, and Novartis. All other authors have declared no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
39. A proof-of-concept of cross-luminescent metascintillators: testing results on a BGO:BaF 2 metapixel.
- Author
-
Konstantinou G, Latella R, Moliner L, Zhang L, Benlloch JM, Gonzalez AJ, and Lecoq P
- Subjects
- Positron-Emission Tomography methods, Ultraviolet Rays, Algorithms, Scintillation Counting methods, Luminescence, Photons
- Abstract
Objective : Time-of-flight positron emission tomography (PET) is the next frontier in improving the effective sensitivity. To achieve superior timing for time-of-flight PET, combined with high detection efficiency and cost-effectiveness, we have studied the applicability of BaF2 in metascintillators driven by the timing of cross-luminescence photon production. Approach : Based on previous simulation studies of energy sharing and analytic multi-exponential scintillation pulse, as well as sensitivity characteristics, we have experimentally tested a pixel of 3 × 3 × 15 mm3 based on 300 μ m BGO and 300 μ m BaF2 layers. To harness the deep ultraviolet cross-luminescent light component, which carries improved timing, we use the FBK VUV SiPM. Metascintillator energy sharing is addressed through a double integration approach. Main results : We reach an energy resolution of 22%, comparable to an 18% resolution of simple BGO pixels using the same readout, through the optimized use of the integrals of the metascintillator pulse in energy sharing calculation. We measure the energy sharing extent of each pulse with a resolution of 25% and demonstrate that experimental and simulation results agree well. Based on the energy sharing, a timewalk correction is applied, exhibiting significant improvements for both the coincidence time resolution (CTR) and the shape of the timing histogram. We reach 242 ps CTR for the entire photopeak, while for a subset of 13% of the most shared events, the CTR value improves to 108 ps, comparable to the 3 × 3 × 5 mm3 LYSO:Ce:Ca reference crystal. Significance : While we are considering different ways to improve further these results, this proof-of-concept demonstrates the applicability of cross-luminescence for metascintillator designs through the application of VUV compatible SiPM coupling, and easily implementable digital algorithms. This is the first test of BaF
2 -based metascintillators of sufficient stoppng power to be included in a PET scanner, demonstrating the industrial applicability of such cross-luminescent metascintillators., (Creative Commons Attribution license.)- Published
- 2023
- Full Text
- View/download PDF
40. Acquired Mechanisms of Resistance to Osimertinib-The Next Challenge.
- Author
-
Ríos-Hoyo A, Moliner L, and Arriola E
- Abstract
EGFR-mutated tumors represent a significant percentage of non-small cell lung cancer. Despite the increasing use of osimertinib, a treatment that has demonstrated an outstanding clinical benefit with a tolerable toxicity profile, EGFR tumors eventually acquire mechanisms of resistance. In the last years, multiple mechanisms of resistance have been identified; however, after progressing on osimertinib, treatment options remain bleak. In this review, we cover the most frequent alterations and potential therapeutic strategies to overcome them.
- Published
- 2022
- Full Text
- View/download PDF
41. "Can Anybody Help Me?" High School Teachers' Experiences on LGBTphobia Perception, Teaching Intervention and Training on Affective and Sexual Diversity.
- Author
-
Aguirre A, Moliner L, and Francisco A
- Subjects
- Humans, Perception, Sexual Behavior, Students, Teaching, School Teachers, Schools
- Abstract
This article analyzes the perceptions of sexual affective diversity among teachers in Spanish high schools. Specifically, we address LGBTphobia, and teacher intervention and training through a survey study of 119 teachers. We administered a questionnaire to investigate these issues based on other studies. The data were analyzed on the basis of descriptive statistics. We attempted to answer three research questions: How do teachers analyze LGBTphobia in high schools? What is their experience and teaching intervention with regard to affective and sexual diversity? What perception exists in high schools about the need for training and education on affective and sexual diversity? The study concludes that high schools and their communities remain hostile places for LGBT students. Therefore, incorporating training into teaching practice and rethinking pedagogy from a queer perspective is fundamental to building an inclusive educational culture.
- Published
- 2021
- Full Text
- View/download PDF
42. Fast Energy Dependent Scatter Correction for List-Mode PET Data.
- Author
-
Álvarez-Gómez JM, Santos-Blasco J, Moliner Martínez L, and Rodríguez-Álvarez MJ
- Abstract
Improvements in energy resolution of modern positron emission tomography (PET) detectors have created opportunities to implement energy-based scatter correction algorithms. Here, we use the energy information of auxiliary windows to estimate the scatter component. Our method is directly implemented in an iterative reconstruction algorithm, generating a scatter-corrected image without the need for sinograms. The purpose was to implement a fast energy-based scatter correction method on list-mode PET data, when it was not possible to use an attenuation map as a practical approach for the scatter degradation. The proposed method was evaluated using Monte Carlo simulations of various digital phantoms. It accurately estimated the scatter fraction distribution, and improved the image contrast in the simulated studied cases. We conclude that the proposed scatter correction method could effectively correct the scattered events, including multiple scatters and those originated in sources outside the field of view.
- Published
- 2021
- Full Text
- View/download PDF
43. Gamma Camera Imaging with Rotating Multi-Pinhole Collimator. A Monte Carlo Feasibility Study.
- Author
-
Ilisie V, Moliner L, Morera C, Nuyts J, and Benlloch JM
- Subjects
- Artifacts, Feasibility Studies, Humans, Monte Carlo Method, Phantoms, Imaging, Gamma Cameras, Tomography, Emission-Computed, Single-Photon
- Abstract
In this work, we propose and analyze a new concept of gamma ray imaging that corresponds to a gamma camera with a mobile collimator, which can be used in vivo, during surgical interventions for oncological patients for localizing regions of interest such as tumors or ganglia. The benefits are a much higher sensitivity, better image quality and, consequently, a dose reduction for the patient and medical staff. This novel approach is a practical solution to the overlapping problem which is inherent to multi-pinhole gamma camera imaging and single photon emission computed tomography and which translates into artifacts and/or image truncation in the final reconstructed image. The key concept consists in introducing a relative motion between the collimator and the detector. Moreover, this design could also be incorporated into most commercially available gamma camera devices, without any excessive additional requirements. We use Monte Carlo simulations to assess the feasibility of such a device, analyze three possible designs and compare their sensitivity, resolution and uniformity. We propose a final design of a gamma camera with a high sensitivity ranging from 0.001 to 0.006 cps/Bq, and a high resolution of 0.5-1.0 cm (FWHM), for source-to-detector distances of 4-10 cm. Additionally, this planar gamma camera provides information about the depth of source (with approximate resolution of 1.5 cm) and excellent image uniformity.
- Published
- 2021
- Full Text
- View/download PDF
44. Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage.
- Author
-
Conde-Estévez D, Monge-Escartín I, Ríos-Hoyo A, Monzonis X, Echeverría-Esnal D, Moliner L, Duran-Jordà X, Taus Á, and Arriola E
- Subjects
- Age Factors, Aged, Antineoplastic Agents, Immunological adverse effects, Body Mass Index, Carcinoma, Non-Small-Cell Lung mortality, Female, Hospitals, University, Humans, Immune Checkpoint Inhibitors adverse effects, Lung Neoplasms mortality, Male, Middle Aged, Prognosis, Progression-Free Survival, Proportional Hazards Models, Retrospective Studies, Sex Factors, Socioeconomic Factors, Antineoplastic Agents, Immunological therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Immune Checkpoint Inhibitors therapeutic use, Lung Neoplasms drug therapy
- Abstract
Our aim was to describe the incidence and characteristics of immune-related adverse events (irAEs) in patients with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI) and to evaluate their impact on outcome. All cases of NSCLC patients treated with ICIs in the second-line setting between December 2015 and May 2018 were evaluated. Seventy patients were included. Mean age was 65.9 years, and the majority of male ( n = 53, 75.7%), with PS of 0-1 ( n = 62, 88.6%) treated with nivolumab ( n = 51; 72.9%). Thirty-one patients (44.3%) experienced an AE, 5 (7.1%) were grades 3-4. Median OS in patients with AE was 30.1 months (95% CI, 16.7-43.5) compared with 5.1 months (95% CI, 1.2-9.0) in cases without AE (log-rank test: p = 0.010). The adjusted HR for OS was 0.46 (95% CI, 0.25-0.86) for the irAE occurrence and 3.60 (95% CI, 1.56-8.32) for PS 2-3 group. The development of irAEs was associated with improved patient outcome.
- Published
- 2021
- Full Text
- View/download PDF
45. Uses and Perceptions of Music in Times of COVID-19: A Spanish Population Survey.
- Author
-
Cabedo-Mas A, Arriaga-Sanz C, and Moliner-Miravet L
- Abstract
Since March 14, 2020, Spanish citizens have been confined to their homes due to the impact of the COVID-19 pandemic. Participating in musical activities has been associated with reduced anxiety and increased subjective wellbeing. The aim of this study is to analyze how Spanish citizens used music during the lockdown period. We also study perceptions of the impact music has in everyday life, in particular examining the respondents' insights into the effects of listening to music in situations of isolation. The study was conducted using the MUSIVID19 questionnaire administered to a total of 1868 Spanish citizens. The results indicate that during lockdown, respondents perceived an increase in the time they devoted to musical activities such as listening, singing, dancing or playing an instrument. The participants also reported using music to cope with the lockdown, finding that it helped them to relax, escape, raise their mood or keep them company. The findings suggest an improvement in their perception of the value of music in personal and social wellbeing during the lockdown. However, the study reveals significant differences in the use and perceptions of music according to respondents' personal situations. Age and feelings of vulnerability may lead to more conservative uses of musical practice and to more moderate perceptions of the positive values of music., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Cabedo-Mas, Arriaga-Sanz and Moliner-Miravet.)
- Published
- 2021
- Full Text
- View/download PDF
46. Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC.
- Author
-
Rocha P, Ramal D, Ripoll E, Moliner L, Corbera A, Hardy-Werbin M, Orrillo M, Taus Á, Zuccarino F, Gibert J, Perera-Bel J, Casadevall D, and Arriola E
- Abstract
Introduction: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different assessment methods, have led to increasing controversy regarding the concept of HPD., Methods: Consecutive patients treated with nivolumab (N = 42) or docetaxel (N = 37) were evaluated. HPD was quantified by applying three different methods (tumor growth rate [TGR], tumor growth kinetics [TGK], and Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1]). HPD rates were compared between and within both cohorts using the different methods., Results: Using TGR, TGK, and RECIST 1.1, we identified seven (16.7%), seven (16.7%), and six (14.3%) patients with HPD in the nivolumab cohort and three (8.1%), four (10.8%), and five (13.6%) in the docetaxel cohort, respectively. We observed a higher concordance between TGR and TGK (90.1%) compared with RECIST 1.1 (31.3% and 37.5% with TGR and TGK, respectively). We found no significant differences in the overall survival between patients with progressive disease and HPD in either cohort., Conclusions: TGR and TGK revealed high concordance rates for identifying patients with HPD in NSCLC. The incidence of HPD was numerically higher in patients treated with immune checkpoint inhibitors. Standardization of methods for measuring HPD and its exploration in larger studies are needed to establish its clinical meaning in NSCLC., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
47. Peer Tutoring Effects on Students' Mathematics Anxiety: A Middle School Experience.
- Author
-
Moliner L and Alegre F
- Abstract
In this research the effects of reciprocal peer tutoring on students' mathematics anxiety levels were examined. A pretest posttest with control group design was used at a public middle school in Spain. A total of 420 students in 7th, 8th, and 9th grades participated in the study, of which 215 were female and 205 were male. Students were randomly assigned and equally distributed by course grade (140 in each course grade) and experimental condition (210 in the experimental group and 210 in the control group). Quantitative data were gathered using the Mathematics Anxiety Scale developed by Chiu and Henry (1990). Qualitative information was gathered during eight focus group sessions that were held with students. Two main factors were analyzed using the quantitative and qualitative information: mathematics learning anxiety and mathematics evaluation anxiety. Results were analyzed by gender and course grade. Statistically significant improvements were reported for both male and female students in the experimental group and for each course grade for both factors. No statistically significant differences were reported for students in the control group in any case. A moderate effect size was reported for mathematics evaluation anxiety (Hedge's g = 0.42), and a large effect size was reported for mathematics learning anxiety (Hedge's g = 0.84). Information obtained from the focus groups was consistent with the reported quantitative results. The main conclusion is that peer tutoring may be very beneficial for reducing middle school students' mathematics anxiety, regardless of their gender or grade., (Copyright © 2020 Moliner and Alegre.)
- Published
- 2020
- Full Text
- View/download PDF
48. Author Correction: High resolution and sensitivity gamma camera with active septa. A first Monte Carlo study.
- Author
-
Ilisie V, Moliner L, Oliver S, Sánchez F, González AJ, Seimetz M, Rodríguez-Álvarez MJ, and Benlloch JM
- Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2020
- Full Text
- View/download PDF
49. Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab.
- Author
-
Moliner L, Capellades J, Taus Á, and Arriola E
- Published
- 2020
- Full Text
- View/download PDF
50. Pilot performance of a dedicated prostate PET suitable for diagnosis and biopsy guidance.
- Author
-
Cañizares G, Gonzalez-Montoro A, Freire M, Lamprou E, Barrio J, Sanchez F, Benlloch JM, Hernandez L, Moliner L, Vidal LF, Torres I, Sopena P, Vera-Donoso CD, Bello P, Barbera J, and Gonzalez AJ
- Abstract
Background: Prostate cancer (PCa) represents one of the most common types of cancers facing the male population. Nowadays, to confirm PCa, systematic or multiparametric MRI-targeted transrectal or transperineal biopsies of the prostate are required. However, due to the lack of an accurate imaging technique capable to precisely locate cancerous cells in the prostate, ultrasound biopsies sample random parts of the prostate and, therefore, it is possible to miss regions where those cancerous cells are present. In spite of the improvement with multiparametric MRI, the low reproducibility of its reading undermines the specificity of the method. Recent development of prostate-specific radiotracers has grown the interest on using positron emission tomography (PET) scanners for this purpose, but technological improvements are still required (current scanners have resolutions in the range of 4-5 mm)., Results: The main goal of this work is to improve state-of-the-art PCa imaging and diagnosis. We have focused our efforts on the design of a novel prostate-dedicated PET scanner, named ProsPET. This system has small scanner dimensions defined by a ring of just 41 cm inner diameter. In this work, we report the design, implementation, and evaluation (both through simulations and real data) of the ProsPET scanner. We have been able to achieve < 2 mm resolution in reconstructed images and high sensitivity. In addition, we have included a comparison with the Philips Gemini-TF scanner, which is used for routine imaging of PCa patients. The ProsPET exhibits better contrast, especially for rod sizes as small as 4.5 mm in diameter. Finally, we also show the first reconstructed image of a PCa patient acquired with the ProsPET., Conclusions: We have designed and built a prostate specific PET system, with a small footprint and improved spatial resolution when compared to conventional whole-body PET scanners. The gamma ray impact within each detector block includes accurate DOI determination, correcting for the parallax error. The potential role of combined organ-dedicated prostate-specific membrane antigen (PSMA) PET and ultrasound devices, as a prebiopsy diagnostic tool, could be used to guide sampling of the most aggressive sites in the prostate.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.